SA
GRAL

Strategic Advocates’s GRAIL Inc GRAL Stock Holding History

Strategic Advocates’s Portfolio GRAL Stock Details GRAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77
Closed -$6.57K – 643
2025
Q4 		$6.57K Hold
77
– – ﹤0.01% 406
2025
Q3 		$4.55K Buy
+77
New +$2.94K ﹤0.01% 420

Other funds holding GRAL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Strategic Advocates's GRAL Position: Q1 2026 in Review

Strategic Advocates sold out of GRAIL Inc (GRAL) in Q1 2026, closing a stake of 77 shares — an estimated $6.57K sold.

Strategic Advocates first reported a position in GRAL in Q3 2025 and held it in 2 quarters. The position peaked at $6.57K in Q4 2025. 364 funds tracked by Wall St. Rank hold GRAL as of Q1 2026.

  • Strategic Advocates reported no remaining GRAIL Inc position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 77 GRAIL Inc shares in Q1 2026, an estimated $6.57K.
  • Strategic Advocates first reported a position in GRAIL Inc in Q3 2025 and held it in 2 quarters.
  • Strategic Advocates's GRAIL Inc position peaked at $6.57K in Q4 2025.
  • 364 funds tracked by Wall St. Rank held GRAIL Inc as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.